Register for an account


Enter your name and email address below.

Your email address is used to log in and will not be shared or sold. Read our privacy policy.


Website access code

Enter your access code into the form field below.

If you are a Zinio, Nook, Kindle, Apple, or Google Play subscriber, you can enter your website access code to gain subscriber access. Your website access code is located in the upper right corner of the Table of Contents page of your digital edition.

Planet Earth

Making Influenza: my story in tomorrow's New York Times

The LoomBy Carl ZimmerMarch 6, 2012 3:46 AM


Sign up for our email newsletter for the latest science news


The ongoing controversy over experimental strains of bird flu is one of those multi-dimensional stories that you just can't fit into one article. I've written about it at Slate and here at the Loom, and I can point elsewhere to no end of excellent stuff. Fellow Discover blogger Ed Yong has a sharp, concise round-up on the research over at Nature, for example, and Michael Specter has a new story on it in this week's New Yorker (subscription required, alas). In tomorrow's New York Times, I take a look into one dimension of the story that has seemed under-explored to me. The controversy over the bird flu revolves around the risk that publishing the full details of the research could lead someone to recreate the virus and unleash a pandemic. Not just a terrorist or a hostile nation, but perhaps even a so-called "garage scientist" toiling at home. Is this a realistic risk, or unfounded fear? After talking to virologists who make viruses for a living and DIY biologists who don't, I find that the answer is pretty complicated. Check it out.[Flue virus image: ESRF]

    3 Free Articles Left

    Want it all? Get unlimited access when you subscribe.


    Already a subscriber? Register or Log In

    Want unlimited access?

    Subscribe today and save 50%


    Already a subscriber? Register or Log In